MintNeuro develops semiconductor components for implantable neural devices. The company sits in the enabling infrastructure layer of neurotechnology, supplying purpose-built chips for neural implants rather than developing a therapeutic product itself. Its positioning is centered on reducing the size, power demands, and development complexity of next-generation neural interfaces.

Its platform is built around modular, ultra-low-power integrated circuits designed for neural signal acquisition, on-chip signal processing and data reduction, electrical stimulation and safety control, power management, and wireless data transfer. MintNeuro states that its chips support modalities including EEG, EMG, ECoG, and LFP, and are intended to integrate into minimally invasive implant architectures. The company presents these components as scalable from preclinical research systems through to commercial implantable devices.

MintNeuro’s current use context is primarily clinical and translational rather than consumer-facing. Publicly described collaborations include work on epilepsy monitoring and a neuromodulation therapy chipset initially targeting mixed urinary incontinence, with broader relevance to conditions such as Parkinson’s disease, dementia, and depression. This places the company within the broader ecosystem as a semiconductor partner to device makers, research institutions, and consortia building implantable neurotechnology systems.